跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPILIM IV sodium valproate 400 mg powder for injection with diluent - TGA Drug Approval Details
Approvals
/
TGA
/
EPILIM IV sodium valproate 400 mg powder for injection with diluent
Approved
STANDARD
EPILIM IV sodium valproate 400 mg powder for injection with diluent
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
1b4f955b55bf3b02
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1b4f955b55bf3b02
Product Name
EPILIM IV sodium valproate 400 mg powder for injection with diluent
Artg Id
104416
Artg Name
EPILIM IV sodium valproate 400 mg powder for injection vial with diluent ampoule
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2005-11-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f1880d26c9bc4e8eab089dd4f819daa1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2d92389de61d587847611edb1238cc31.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
1b4f955b55bf3b02
Type
Standard
Back to TGA Approvals